Part 2 Insurance companies: Fixed margin Want costs to rise predictably and steadily, not by surprise In support of GLP1s over time, not immediately, so they can be priced in PBMs: Benefit from higher priced drugs with rebates Pharmacies: Benefit from volume of prescriptions Benefit from foot traffic from prescriptions Pharma: Benefit from blockbuster drugs Summary of existing players: four key stakeholders benefit from higher priced blockbusters drugs over a long-term time horizon under most circumstances
74 YuanJ.LiuW.JiangX.HuangY.ZongL.DingH.et al (2024)
Though we conducted a longer-term follow-up analysis in the T2D population, future studies are necessary to evaluate long-term associations of semaglutide in patients with obesity and patients with T2D
They are earned, not purchased, and are held by only a small percentage of U.S
They are the same problem showing up in two places
Now, Enter GLP-1 Receptor Agonists GLP-1 receptor agonists act centrally and peripherally
